MDK and neoplasm: This supports that MDK-NCL may promote an immune-resistant TME through T cell exclusion rather than direct T cell exhaustion, a mechanism distinct from PD-1/PD-L1, which primarily induces T cell dysfunction at the tumor-immune interface.